Myeloma Patients Who Relapse After CAR T-Cell Therapy Have Options
Samir Parekh, MD, and, Oliver Van Oekelen, MD, PhD, discuss their study finding that therapies that engage T cells—a type of white blood cell that protects the body from infection—could provide benefits for patients with relapsed or refractory multiple myeloma, a cancer of the plasma cells.
![Test tubes](/files/MSHealth/Assets/Global/Newsroom/2021/ISMMS-Spotlight-Placeholder-2col-770x420-7.jpg)
Diabetes May Accelerate Blood Cancer Growth, Yet Survival Outcomes Differ by Race
Sep 29, 2023 View All Press Releases![Researcher using microscope](/files/MSHealth/Assets/Global/Newsroom/2021/ISMMS-Spotlight-Placeholder-2col-770x420-17.jpg)
Researchers Find Treatment Options for Patients Whose Blood Cancer Relapses After CAR-T
Nov 04, 2022 View All Press Releases![New York skyscrapers](/files/MSHealth/Assets/Global/Newsroom/2021/ISMMS-Spotlight-Placeholder-2col-770x420-3.jpg)
Potentially Serious Side Effect Seen in Patient after Immunotherapy
Dec 10, 2021 View All Press Releases